Spots Global Cancer Trial Database for persistent cervical carcinoma
Every month we try and update this database with for persistent cervical carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer | NCT05310383 | Recurrent Cervi... Metastatic Cerv... Persistent Cerv... Radiotherapy Immunotherapy Anti-programmed... Immune Checkpoi... Tislelizumab Objective Respo... Survival Outcom... | Tislelizumab pl... | 18 Years - | Peking Union Medical College Hospital |